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Objective: To assess the changes in incidence, use of mechanical ventilation, length of stay
(LOS), costs and mortality of children (0e15 years) and young adults (16e45 years) hospitalized
for asthma exacerbations.
Methods: We included patients hospitalized for asthma exacerbations in Spain from 2002 to
2010 (ICD9-CM codes 493.0xe493.9x). The data were collected from the National Hospital
Discharge Database (entire population). We calculated the yearly age- and sex-specific inci-
dence rates for each of the two groups.
Results: We included a total of 12,038 pediatric patients and 2792 young adults hospitalized
for asthma exacerbations. Overall crude incidence decreased from 20.5 to 18.7 admissions
per 100.000 inhabitants in the pediatric group (p < 0.05), and from 4.12 to 3.68 admissions
per 100.000 inhabitants among young adults, from 2002 to 2010 (p < 0.05). By contrast, we
detected a significant increase in the use of non-invasive ventilation (NIV) in both groups.of Respiratory Medicine, Hospital General Universitario Gregorio Maran˜o´n, C/ Doctor Esquerdo 46,
d.madrid.org (J. de Miguel-Dı´ez).
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984 J. de Miguel-Dı´ez et al.The average LOS decreased during the study period, from 3.71 (SD 2.28) to 3.16 (SD 2.11) days
(p < 0.05) among pediatric patients and there were not changes among young adults. During
the study period, the mean cost per patient decreased from 1558.53 (SD 443.63) to 1378.41
(SD 472.71) euros in the pediatric group (p < 0.05), while increased from 2183.44 (SD
783.15) to 2564.32 (SD 1933.98) euros among young adults (p < 0.05).
Conclusion: Our results suggest a decrease in the incidence of hospital admissions for asthma
exacerbations with concomitant increase in use of NIV in asthmatic patients, both pediatric
and young adults patients. Although LOS and mean cost have decreased among pediatric pa-
tients, they have not changed and increased, respectively, among young adults. A better man-
agement of the disease at primary care services may explain the improvement in the incidence
and outcomes.
ª 2014 Elsevier Ltd. All rights reserved.Background
Asthma, a chronic respiratory disease characterized by
episodic airway obstruction, hyper-responsiveness, and
inflammation, continues to be a major public health prob-
lem throughout the world because of its prevalence and
morbidity [1,2]. Around 300 million individuals of all ages
worldwide suffer from this disease, which causes 250,000
deaths per year [1]. In Spain, the prevalence of asthma in
children aged 6e7 years is 10.7% for boys and 8.2% for girls,
and in children aged 13e14 years, the respective rates are
9.3% and 9.2% [3]. On the other hand, approximately 5% of
the Spanish adult population has asthma [4,5].
When inappropriately treated, the complications asso-
ciated with asthma can result in increased exacerbations
and hospital admission [6]. Asthma hospitalizations repre-
sent a serious adverse outcome that is theoretically pre-
ventable with high-quality healthcare, patient education
and optimal treatment of asthma [7]. The number and
duration of hospitalization, admissions to the ICU and need
of mechanical ventilation affect the cost of asthma signif-
icantly. In fact, hospitalizations are known to be an
important driver of asthma-related direct healthcare costs
[7]. Therefore, to improve outcomes, we need to optimize
the management of this disease.
Hospital admissions for asthma are one of the best
sources of information of trends and prognosis in the
morbidity of the disease, but there is no data available in
many countries [8]. Collecting data about hospitalizations
for asthma exacerbations is important at a country level to
evaluate the incidence, patient characteristics and
outcome of the hospital admissions in variables such use of
mechanical ventilation, length of stay, mortality and
burden of disease. In Spain, there are no recent data on
hospital admissions for asthma exacerbations at a national
level, neither among pediatric patients neither in adults.
However, Gonzalez-Barcala et al. [8] found a significant
increase in hospital admissions due to asthma in individuals
aged 15 years or above in the Galician region between the
years 1995e2009. These data are opposite to those found in
most developed countries, where it has been observed a
decreasing trend [9]. Comparisons of hospital admissions
for asthma exacerbations and outcomes between countries
could provide information that would help to understand
the possible differences and would also aid for planning theprovision of healthcare services. The discharge database
provides a large alternative information source to describe
and analyze the trends and characteristics of hospitaliza-
tions for asthma exacerbations at a national level.
The aim of this study was to analyze national repre-
sentative hospital discharge data, collected from 2002 to
2010 years, to elucidate changes in the incidence, inpatient
healthcare utilization for asthma such us in-hospital use of
mechanical ventilation, length of hospital stay (LOS), costs
and in-hospital mortality (IHM) of patients (children and
young adults) hospitalized for asthma exacerbations in
Spain over time.
Methods
A retrospective, descriptive, epidemiology study was con-
ducted using the Spanish National Hospital Database
(CMBD, Conjunto Minimo Ba´sico de Datos), which compiles
all the public and private hospital data, hence covering
more than 95% of hospital discharges. The CMBD database is
managed by the Spanish Ministry of Health and Social Policy
and Equality and includes patients’ variables (sex, date of
birth), date of admittance, date of discharge, up to 14
discharge diagnosis, and up to 20 procedures performed
during the admission. The Spanish Ministry of Health and
Social Policy and Equality sets standards for registration
and performs periodic audits [10].
We selected all admissions of patients who were diag-
nosed with acute asthma exacerbation as the primary
diagnosis using the International Classification Diseases-
Ninth Revision, Clinical Modification (ICD-9-CM). Procedure
codes used were: 493.0xe493.9x. We analyze pediatric
patients (0e15 years) and young adults (16e45 years old)
separately. We calculated the yearly age- and sex-specific
incidence rates for each of the two groups. The proportion
of patients that died during the hospital admissions (IMH),
LOS, and costs were also estimated for each year studied.
Costs were calculated using Diagnosis-Related Groups (GRD)
for the disease. GRD represents a medical-economic entity
concerning a set of diseases requiring analogous manage-
ment resources [11]. All costs shown are adjusted for the
increment of the inflation in the same period in Spain.
We analyzed the use of ventilatory support during ad-
missions for acute asthma exacerbations. Use of non-
invasive ventilation (NIV) and invasive mechanical
Hospital admissions for asthma exacerbations 985ventilation (IMV) was determined based on procedure codes
93.90 and 96.04, respectively. If both procedures were used
the patient was included in the IMV group.
Statistical analysis
A descriptive statistical analysis was performed. We calcu-
lated the yearly age- and sex-specific incidence rates for
hospitalizationsbyacuteasthmaexacerbationbydividing the
number of cases by year, sex, and age group by the corre-
sponding number of people in that population group accord-
ing to data from the Spanish National Institute of Statistics, as
reported at December 31 of each year [12]. The incidence
rates were expressed in terms of 100,000 inhabitants.
In our study we apply joinpoint log lineal regression to
identify the years in which changes in tendency occurred in
the rates for admissions for asthma exacerbations among
children and young adults, as well as to estimate the annual
percentage of change (APC) in each of the periods delimi-
ted by the points of change. The analysis started with the
minimum number of joinpoints and tested if the inclusion of
one or more joinpoints were statistically significant [13]. In
the final model, each joinpoint indicated a significant
change in the tendency, and the APC was obtained in each
of the segments delimited by the joinpoints, by means of
the technique of weighted least squares. The Joinpoint
Regression Program, version 4.0.4 was used for the analysis
[14].
Data were treated with full confidentiality, according to
the Spanish legislation. Patient identifiers were deleted
before the database was provided to the authors in order to
keep strict patient confidentiality. It is not possible to
identify patients at individual levels either in this paper or
in the database. Given the anonymous and mandatory na-
ture of the data informed consent was neither required nor
necessary. The Spanish Ministry of Health evaluated the
protocol of our investigation and considered that it met all
ethical aspects according to the Spanish legislation so
provided us the anonymous database. For all the previous
reasons the requirement for ethical approval was not
necessary.
Results
We identified a total of 12,038 pediatric patients and 2792
young adults hospitalized for asthma exacerbations from
2002 to 2010. Mean age was 5.79 years (SD, 3.54 years) in
pediatric patients and 30.15years (SD, 8.77years) in young
adults.
Tables 1 and 2 reflect the total number of hospitaliza-
tions and the incidence of hospital admissions for asthma
exacerbations per 100,000 inhabitants in each year. The
overall crude incidence has decreased from 20.5 to 18.7
hospitalizations per 100,000 inhabitants in pediatric pa-
tients and from 4.12 to 3.68 hospitalizations per 100,000
inhabitants in young adults from 2002 to 2010 in Spain
(p < 0.05). When we compared incidence by sexes, we
found higher incidence in men than in women for all years
analyzed in pediatric patients. By contrast, we found higher
incidence in women than in men in young adults hospital-
ized for asthma exacerbations.Figs. 1 and 2 shows the time evolution of hospitalizations
for asthma exacerbations, in pediatric patients (0e15
years) and in young adults (16e45 years) respectively, ac-
cording to joinpoint analysis, by sex groups and in total. As
can be seen, the incidence of hospitalizations is declining in
children at an annual percent change (APC) of around 4.2%
for both sexes. Among young adults the APC is slightly
higher for men (3.67%) than women (2.56%).
Regarding treatment, we observed changes in the use of
ventilatory support during acute asthma exacerbations
from 2002 to 2010. In this sense, we detected a significant
increase in the use of NIV in both groups, pediatric patients
(Table 3) and young adults (Table 4). However, the use of
IMV was not significantly reduced over time in neither case.
In our study, the mean LOS for hospital admissions for
asthma exacerbations in pediatric patients decreased
significantly from 3.71 (2.88) days in 2002 to 3.16 (2.11)
days in 2010 (p < 0.05). In young adults, the mean LOHS for
hospital admissions for asthma exacerbations was 5.36
(4.02) days in 2002 and 5.16 (5.39) days in 2010, but no
significant changes were detected over the period of study.
The mean cost per patient decreased from 1558.53
(443.63) Euros in 2002 to 1378.41 (472.71) Euros in 2010 in
the group of pediatric patients (p < 0.05). By contrast, the
mean cost per patient increased from 2183.44 (783.15)
Euros in 2002e2564.32 (1933.98) Euros in 2010 in young
adults (p < 0.05).
IHM was very low. Throughout the study period, only 1
patient (0.09%) died in the group of pediatric patients and 3
patients (0.31%) died in the group of young adults. No sig-
nificant changes were detected over the period of study in
neither case.Discussion
Using the Spanish National Hospital Database, we found a
significant decrease in the hospitalizations rates for asthma
exacerbations from 2002 to 2010 among pediatric patients
and young adults. In contrast, use of NIV increased signifi-
cantly over this same period in both groups. Other marked
temporal trends seen over the study period included a
decrease of mean LOS and costs among pediatric patients
and an increase of costs among young adults. IHM was
negligible during the study period. As there are no similar
studies in Spain, it is necessary to make comparisons with
other countries.
In the last decades of the twentieth century, hospital
admission rates for childhood asthma patients increased in
many countries, suggesting a worldwide trend [15e17]. In
this sense, Rottemet al [6] found a significant increase in
admissions for childhood asthma from 1990 to 1999. Later,
Akimbami et al. [18] reported, after a significant increase
in the 1980s, a non significant annual decrease in the hos-
pitalization rate for childhood asthma between 1991 and
2006 using the National Hospital Discharge Survey. Howev-
er, as in our own, more recent studies have shown a sig-
nificant decline in asthma hospitalizations among children
[7,19,20]. Although unclear, the decrease in hospitaliza-
tion rate may be explained by a decrease in the frequency
and severity of asthma exacerbations. However, it could be
argued that cases of severe asthma are becoming more
Table 1 Incidence rates per 100,000 inhabitants, mean length of stay (LOS) and costs of pediatric patients (0e15 years) hospitalized for asthma exacerbation in Spain from
2002 to 2010.
2002 2003 2004 2005 2006 2007 2008 2009 2010
0e2 yearsa
N (Rate
per 100,000 )
397 (33.33) 390 (31.45) 439 (34.08) 447 (33.74) 629 (46.05) 402 (28.87) 407 (28.41) 422 (28.72) 466 (30.97)
3e5 yearsa
N (Rate
per 100,000 )
309 (27.77) 381 (33.07) 419 (34.87) 350 (27.96) 439 (33.98) 241 (18.03) 297 (21.54) 301 (21.23) 374 (26.13)
6e8 yearsa
N (Rate
per 100,000 )
232 (20.25) 233 (20.22) 264 (22.7) 218 (18.5) 317 (26.25) 206 (16.44) 207 (15.8) 205 (15.21) 240 (17.41)
9e12 yearsa
N (Rate
per 100,000 )
261 (15.91) 253 (15.42) 255 (15.59) 219 (13.48) 232 (14.31) 166 (10.21) 160 (9.7) 162 (9.64) 194 (11.3)
13e15 Yearsa
N (Rate
per 100,000 )
116 (8.76) 127 (9.68) 116 (8.88) 118 (9.07) 97 (7.49) 114 (8.85) 86 (6.7) 60 (4.69) 70 (5.51)
Totala
N (Rate
per 100,000 )
1315 (20.5) 1384 (21.3) 1493(22.64) 1352 (20.21) 1714 (25.26) 1129 (16.4) 1157 (16.57) 1150 (16.24) 1344 (18.7)
Male
N (%)
822 (62.51) 866 (62.57) 923 (61.82) 816 (60.36) 1062 (61.96) 696 (61.65) 737 (63.7) 694 (60.35) 854 (63.54)
Female
N (%)
493 (37.49) 518 (37.43) 570 (38.18) 536 (39.64) 652 (38.04) 433 (38.35) 420 (36.3) 456 (39.65) 490 (36.46)
LOSa
Mean
(days) (sd)
3.71 (2.88) 3.46 (2.45) 3.23 (2.09) 3.51 (2.6) 3.3 (2.05) 3.42 (2.5) 3.38 (2.52) 3.21 (2.19) 3.16 (2.11)
Costsa
Mean (V)
(sd)
1558.53
(443.63)
1647.94
(451.23)
2021.43
(515.98)
2016.98
(553.53)
1388.66
(688.01)
1454.81
(799.91)
1347
(656.59)
1401.98
(636.07)
1378.41
(472.71)
a p < 0.05.
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Table 2 Incidence rates per 100,000 inhabitants, mean length of stay (LOH) and costs of young adults (16e45 years) hospitalized for asthma exacerbation in Spain from 2002
to 2010.
2002 2003 2004 2005 2006 2007 2008 2009 2010
16e25 yearsa
N (Rate
per 100,000 )
285 (4.85) 407 (7.05) 328 (5.8) 302 (5.48) 274 (5.11) 287 (5.49) 221 (4.34) 246 (4.94) 225 (4.62)
26e35 yearsa
N (Rate
per 100,000 )
281 (4.09) 387 (5.48) 303 (4.19) 292 (3.96) 347 (4.65) 316 (4.2) 292 (3.88) 280 (3.75) 256 (3.47)
36e45 yearsa
N (Rate
per 100,000 )
215 (3.46) 271 (4.22) 267 (4.04) 289 (4.27) 258 (3.73) 286 (4.05) 276 (3.84) 281 (3.84) 244 (3.28)
Totala
N (Rate
per 100,000 )
781 (4.12) 1065 (5.53) 898 (4.6) 883 (4.49) 879 (4.45) 889 (4.49) 789 (3.98) 807 (4.08) 725 (3.68)
Male
N (%)
282 (36.11) 390 (36.62) 349 (38.86) 312 (35.33) 323 (36.75) 317 (35.66) 276 (34.98) 295 (36.56) 248 (34.21)
Female
N (%)
499 (63.89) 675 (63.38) 549 (61.14) 571 (64.67) 556 (63.25) 572 (64.34) 513 (65.02) 512 (63.44) 477 (65.79)
LOS
Mean
(days) (sd)
5.36 (4.02) 4.82 (3.23) 4.91 (4.59) 5.01 (4.39) 4.72 (3.25) 4.78 (4.03) 5.11 (4.51) 4.94 (4.69) 5.16 (5.39)
Costsa
Mean (V)
(sd)
2183.44
(783.15)
2269.02
(878.33)
2436.9
(1098.78)
2538.84
(1180.02)
2043.09
(1267.4)
2158.38
(1408.25)
2500.34
(1118.54)
2620.66
(3092.75)
2564.32
(1933.98)
a p < 0.05.
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Figure 1 Jointpoint analysis in annual hospital admissions for asthma exacerbations in pediatric patients (0e15 years) in Spain,
2002e2010: boys (1A), girls (1B), total (1C). Footnote: APC: Annual percent change (based on rates that were sex and aged-
adjusted using the Spanish National Statistics Institute projections) calculated by using jointpoint regression analysis. *APC is
significantly different from zero (two-side p < 0.05).
988 J. de Miguel-Dı´ez et al.effectively managed out of hospital [21]. Improvement in
asthma management following the introduction of clinical
guidelines may have contributed as well [1,2].
Among adults, although some authors have found a sig-
nificant increase in hospital admissions for asthma [8],
others have showed a tendency toward a reduction [22,23],
as in our case. The implementation of programs of in-
terventions aimed at organizing healthcare systems,
together with programs of asthma education for health
professionals and patients can help to reduce the number
of hospital admissions [21,24].
Considering that it is assumable that the patients who
are more frequently hospitalized are commonly the most
severe ones, it can be hypothesized that the use of mono-
clonal anti-IgE antibodies in these patients could have a
relevant impact in this sense, since this treatment have
shown a particularly significant effect on asthma exacer-
bations and hospitalizations [25]. Interestingly, whereas in
2006 a huge peak in asthma hospitalizations is patent
among children younger than 13 years of age, the trend
continued decreasing in an almost constant fashion in the
rest of age ranges. However, this drug was introduced in
Spain in 2006 for adolescents and adults, and approved forchildren aged 6 to 12 in 2009. According to data published,
the number of patients receiving it in Spain is still small
[26,27]. Consequently, it is logical to suppose that it will be
necessary more years of follow up to observe the beneficial
effect on hospitalization rates. The explanation for the
year 2006 peak will require further investigation including
the effect of influenza and other respiratory viral infections
in that year among younger children.
In our study, we have shown that declining hospitaliza-
tion rates for asthma contrast with increasing use of NIV,
raising the possibility that advanced respiratory support is
being performed at an earlier phase on less critically ill
patients with asthma exacerbations. Other studies have
also shown an increase in the application of this type of NIV
in emergency care for asthmatic patients [28]. These find-
ings are consistent with a previous study of children with
status asthmatics that reported lower hospitalization rates
and higher intensive care unit admissions between 1992 and
2006 [29]. However, population rates of mechanical venti-
lation were low and stable over time. Trends in asthma
admissions with time in adult critical care units show that
the number of admissions is also rising among adults [30].
These data may indicate trends toward better outpatient
Figure 2 Jointpoint analysis in annual hospital admissions for asthma exacerbations in young adults (16e45 years) in Spain,
2002e2010: men (2A), women (2B), total (2C). Footnote: APC: Annual percent change (based on rates that were sex and aged-
ajusted using the Spanish National Statistics Institute projections) calculated by using jointpoint regression analysis. *APC is
significantly different from zero (two-side p < 0.05).
Table 3 Use of non-invasive ventilation (NIV) and invasive
mechanical ventilation (IMV) for asthma exacerbations in
pediatric patients (0e15 years) in Spain from 2002 to 2010.
NIVa IMV
No Yes No Yes
N % N % N % N %
Year 2002 1303 99.09 12 0.91 1312 99.77 3 0.23
2003 1367 98.77 17 1.23 1383 99.93 1 0.07
2004 1474 98.73 19 1.27 1492 99.93 1 0.07
2005 1340 99.11 12 0.89 1351 99.93 1 0.07
2006 1693 98.77 21 1.23 1710 99.77 4 0.23
2007 1109 98.23 20 1.77 1126 99.73 3 0.27
2008 1133 97.93 24 2.07 1157 100.00 0 0.00
2009 1112 96.70 38 3.30 1144 99.48 6 0.52
2010 1319 98.14 25 1.86 1340 98.70 4 0.30
a p < 0.001.
Table 4 Use of non-invasive ventilation (NIV) and invasive
mechanical ventilation (IMV) for asthma exacerbations in
young adults (16e45 years) in Spain from 2002 to 2010.
NIVa IMV
No Yes No Yes
N % N % N % N %
Year 2002 778 99.62 3 0.38 772 98.85 9 1.15
2003 1061 99.62 4 0.38 1053 98.87 12 1.13
2004 885 98.55 13 1.45 885 98.55 13 1.45
2005 880 99.66 3 0.34 867 98.19 16 1.81
2006 875 99.54 4 0.46 869 98.86 10 1.14
2007 886 99.66 3 0.34 878 99.76 11 1.24
2008 780 98.86 9 1.14 776 98.35 13 1.65
2009 799 99.01 8 0.99 799 99.01 8 0.99
2010 710 97.93 15 2.07 715 98.62 10 1.38
a p < 0.001.
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erbations, a higher threshold for hospital admissions, and a
lower threshold for admissions in critical care units, rather
than any true increase in numbers of those with severe
disease [23,24].
When examining trends in costs, we observed a signifi-
cant decrease for children with asthma during the study
time. The reductions in hospitalizations and LOS may ac-
count for these findings. Other authors have also observed
that inpatient expenditures have decreased during the
same period, while prescription expenditures have
increased [31,32]. However, in our study, the average
annual cost per patient increased among young adults
hospitalized for asthma exacerbations from 2002 to 2010,
despite significant reduction in hospitalization rates in
these patients. Although there may be many reasons for
increasing hospital charges, more intensive use of re-
sources, as we have seen with non-invasive respiratory
support, could help to justify these findings [7]. The lack of
significant reduction in LOS in this group of patients during
the study period may have contributes as well.
IHM was rare in our study, as in others [6,24]. Although
we can not to completely rule out the deaths of patients
who were not admitted, this possibility is highly unlikely.
Reduced mortality may reflect availability and utilization of
healthcare, access to an appropriate use of treatment
modalities and prevention strategies, low severity of dis-
ease, and low prevalence of co- morbidities [6,7].
We should recognize strength and limitations of the
current study. The main strength lies in its large sample size
and its standardized methodology maintained constant
during the study period. Furthermore, discharge databases
have been used by other authors to assess outcomes,
burden and trends of hospital admissions for asthma exac-
erbations [7,20,28]. Nevertheless, our study is subject to a
series of limitations. First, a potential source of bias comes
from use of ICD-9-CM diagnosis codes to identify patients
hospitalized for asthma exacerbations. To use only the
codes 493.0xe493.9x can somehow bias the selection of
patients, particularly among children aged 0e5. Indeed,
there exists a patent reluctance to use the term “asthma”
in children in this group of age, and the use of other
euphemistic alternative terms like “wheeze” or “broncho-
spasm” are commonly used. Considering that the ICD-9-CM
encloses codes not included in the 493.xx group for bron-
chospasm (i.e. 519.11, 466.19, 466.11) and for wheeze (i.e.
786.07) it is conceivable that a significant proportion of
children between 0 and 5 years of age with the same clin-
ical picture have been missed as a consequence of the use
of these alternative codes, and this fact can bias the di-
agnose more in infants and pre-school children than in the
rest of age ranges. However, the Spanish Ministry of Health
included the code 519.11 in year 2008 so we think the ef-
fect on our results would be of a small magnitude. With
regard to codes for bronchiolitis 466.19 and 466.11 (primary
diagnoses), the behavior for the age group 0e4 years has
been similar to that observed for asthma across the study
period. Finally, the code for wheeze (i.e. 786.07) as pri-
mary diagnoses is very rarely used in Spain. So as with the
case of bronchospasm if there is a misclassification bias for
bronchiolitis we believe it has possibly been non differen-
tial so it would not affect much the validity of our results.In relation to older patients, we might have underestimated
or overestimated the frequency of asthma admissions and
misdiagnosed lower respiratory tract infections, such as
bronchitis and pneumonia. However, this is a limitation in
virtually all studies of asthma epidemiology [30] and the
frequency of cross over in this study is unlikely to be
different in any other. In any case, other studies of trends
in asthma hospitalizations have used the same codes, and
those who have conduced sensitivity analyses to address
this issue have concluded that it is difficult to postulate
that diagnostic substitution explains the observed trend
[7]. Second, our data source was the CMBD, an adminis-
trative database that contains discharge data for Spanish
hospitalizations and uses the information that the physician
has included in the discharge report; therefore, it does not
include all the variables of the clinical history such as the
history of asthma and prehospitalization levels of severity
and control, severity of the exacerbations, pharmacologic
treatments, or response to NIV treatment, among others.
Another limitation of this database is its anonymity (no
identifying items such as clinical history number), which
makes it impossible to detect whether the same patient
was admitted more than once during the same year. In
addition, patients who moved from one hospital to another
would appear twice.
Despite these limitations, this dataset, which was
introduced in Spain in 1982, is a mandatory register, its
coverage is estimated to be greater than 95%, and it is
periodically audited [33]. In addition, Spain is a large
country with a public health system providing full free of
charge medical services to the entire population, so pa-
tients come from a variety of socioeconomic categories
improving the external validity of the current results.
In conclusion, this study provides data indicating that
the incidence of hospital admissions for asthma exacerba-
tions decreased in Spain from 2002 to 2010 among children
and young adults, with increased use of NIV and reduced
mortality rates in both groups. Outcomes such as mean LOS
and costs decreased among children while unchanged and
increased, respectively, among young adults. These findings
indicate that, probably, the management of the patients
undergoing asthma exacerbations has improved in Spain
during the study period. In any case, this temporal trend
points to a decrease in the burden of asthma for hospital-
izations in Spain, and may be useful for planning future
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